New therapeutic options for HCV in Central Europe

New therapeutic options became available in 2015 in the European Union. We present the availability of interferon-free regimens with direct acting antivirals (DAA) in four Central European countries – the Czech Republic, Hungary, Poland and Slovakia – which despite similar historical, geographical a...

Descripción completa

Detalles Bibliográficos
Autores principales: Flisiak, Robert, Urbánek, Petr, Rokusz, Laszlo, Oltman, Marian, Makara, Mihaly, Janicko, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497412/
https://www.ncbi.nlm.nih.gov/pubmed/28856265
http://dx.doi.org/10.5114/ceh.2016.58850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497412/
https://www.ncbi.nlm.nih.gov/pubmed/28856265
http://dx.doi.org/10.5114/ceh.2016.58850

Ejemplares similares